Apax Partners, a private equity firm, completed the acquisition of Becton Dickinson’s stake in Vyaire Medical, a company that manufactures and markets products for the diagnosis, treatment and monitoring of respiratory conditions, for $435m. “Since the Apax Funds acquired a majority stake in Vyaire Medical in October 2016, strong progress has been made by the business. A new senior management team led by CEO Dave Mowry has established key functions, delivered operational improvements, upgraded commercial capabilities and made two accretive acquisitions. It was on the basis of this progress, and the promise that we continue to see for the business, that we sought to acquire BD’s minority stake,” Steven Dyson, Apax Partner.